Header Logo

Connection

SAPNA PRADYUMAN PATEL to Standard of Care

Back to Details
This is a "connection" page, showing publications SAPNA PRADYUMAN PATEL has written about Standard of Care.
SAPNA PRADYUMAN PATEL
Connection Strength
0.033
Standard of Care
  1. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.